Reuters logo
a year ago
BRIEF-Pronai licenses cancer drug candidate from Carna Biosciences
May 26, 2016 / 11:42 PM / a year ago

BRIEF-Pronai licenses cancer drug candidate from Carna Biosciences

May 26 (Reuters) - Pronai Therapeutics Inc

* Pronai licenses cancer drug candidate targeting CDC7 from Carna Biosciences

* Qtrly has obtained an exclusive license from Carna Biosciences, Inc., Kobe, Japan

* License for worldwide rights to develop and commercialize as-141, a small molecule kinase inhibitor targeting CDC7

* Will intially pay Carna $0.9 million and additional potential payments upon achievement of certain milestones of upto $270 million

Source text for Eikon:

Further company coverage: (Bengaluru Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below